GC
ABBV icon

Garde Capital’s AbbVie ABBV Stock Holding History

Garde Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Buy
1,483
+81
+6% +$17.4K 0.02% 185
2026
Q1 		$305K Buy
1,402
+34
+2% +$7.54K 0.02% 165
2025
Q4 		$313K Sell
1,368
-86
-6% -$19.6K 0.02% 181
2025
Q3 		$337K Sell
1,454
-116
-7% -$23.6K 0.02% 194
2025
Q2 		$291K Buy
1,570
+235
+18% +$43.7K 0.02% 194
2025
Q1 		$280K Hold
1,335
– – 0.02% 191
2024
Q4 		$237K Buy
1,335
+200
+18% +$36.8K 0.02% 200
2024
Q3 		$224K Hold
1,135
– – 0.01% 198
2024
Q2 		$195K Sell
1,135
-59
-5% -$9.77K 0.01% 208
2024
Q1 		$217K Sell
1,194
-533
-31% -$91.9K 0.02% 197
2023
Q4 		$268K Sell
1,727
-2,675
-61% -$390K 0.02% 177
2023
Q3 		$656K Sell
4,402
-176
-4% -$25.8K 0.06% 115
2023
Q2 		$617K Buy
+4,578
New +$671K 0.05% 126
2019
Q3 		– Sell
-3,765
Closed -$274K – 140
2019
Q2 		$274K Buy
3,765
+255
+7% +$20K 0.04% 117
2019
Q1 		$283K Sell
3,510
-9,368
-73% -$766K 0.05% 113
2018
Q4 		$1.19M Hold
12,878
– – 0.21% 60
2018
Q3 		$1.16M Hold
12,878
– – 0.2% 64
2018
Q2 		$1.19M Sell
12,878
-831
-6% -$81.2K 0.21% 61
2018
Q1 		$1.3M Sell
13,709
-19
-0.1% -$2.09K 0.24% 53
2017
Q4 		$1.33M Sell
13,728
-131
-0.9% -$12.3K 0.25% 51
2017
Q3 		$1.23M Buy
13,859
+9,383
+210% +$714K 0.24% 54
2017
Q2 		$325K Buy
+4,476
New +$301K 0.08% 93
2016
Q4 		– Sell
-10,211
Closed -$556K – 117
2016
Q3 		$556K Buy
+10,211
New +$661K 0.18% 95
2015
Q4 		– Sell
-10,211
Closed -$556K – 109
2015
Q3 		$556K Hold
10,211
– – 0.18% 95
2015
Q2 		$686K Sell
10,211
-148
-1% -$9.66K 0.21% 85
2015
Q1 		$606K Buy
10,359
+895
+9% +$54.1K 0.18% 90
2014
Q4 		$619K Buy
+9,464
New +$597K 0.19% 89

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Garde Capital's ABBV Position: Q2 2026 in Review

Garde Capital increased its AbbVie (ABBV) stake by 5.8% in Q2 2026, buying an estimated $17.4K and bringing the position to 1,483 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #185.

Garde Capital first reported a position in ABBV in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.33M in Q4 2017. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Garde Capital held 1,483 shares of AbbVie worth $373K as of Q2 2026.
  • Garde Capital bought 81 AbbVie shares in Q2 2026, an estimated $17.4K.
  • AbbVie made up 0.02% of Garde Capital's portfolio in Q2 2026, its #185 holding.
  • Garde Capital first reported a position in AbbVie in Q4 2014 and has held it in 27 quarters since.
  • Garde Capital's AbbVie position peaked at $1.33M in Q4 2017.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Garde Capital's 13F filing for Q2 2026, filed 31 Jul 2026.